Company

DaVita Inc.

Headquarters: Denver, CO, United States

Founded: 1979

Employees: 69,000

CEO: Mr. Javier J. Rodriguez

show_chart NYSE: DVA

Market Cap

$12.08 Billion

USD as of April 1, 2022

history Market Cap History

DaVita Inc. market capitalization over time

Evolution of DaVita Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of DaVita Inc.

Detailed Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Wikipedia Introduction

DaVita Inc. provides kidney dialysis services through a network of 2,816 outpatient dialysis centers in the United States, serving 204,200 patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. In 2020, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2020, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2020, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 271st on the Fortune 500. The name "DaVita" was derived from the Italian language phrase "Dare Vita", which means "giving life".

Source: Wikipedia, retrieved on March 31, 2022, 8:57 p.m.

Best-Selling Downloads - US

S&P 500 Companies Excel Download $29.90
Russell 3000 Companies Excel Download $99.90
580 Unicorn Startup Companies – Excel Spreadsheet $29.90

Save tens of hours in 2 minutes!

Product & Services

Dialysis

Key People

Javier J. Rodriguez, CEO Peter Grauer, lead independent director

Financials

Revenue: $11.550 billion (2020)

Net income: $773 million (2020)


Total assets: $16.988 billion (2020)

Total equity: $1.383 billion (2020)

Stocks & Indices

DaVita Inc. has the following listings and related stock indices.


Stock: NYSE: DVA

Stock: Bovespa: DVAI34

Stock: FSX: TRL

Details

Headquarters:

2000 16th Street

Denver, CO 80202

United States

Phone: 720 631 2100